Pulseless ventricular tachycardia: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:


==[[Pulseless ventricular tachycardia classification|Classification]]==
==[[Pulseless ventricular tachycardia classification|Classification]]==
[[Pulseless ventricular tachycardia]] as a [[ventricular tachycardia]],  may be classified based on the [[morphology]] of the [[QRS complexes]] into two subtypes/groups: [[monomorphic ventricular tachycardia]], and [[polymorphic ventricular tachycardia]].


==[[Pulseless ventricular tachycardia pathophysiology|Pathophysiology]]==
==[[Pulseless ventricular tachycardia pathophysiology|Pathophysiology]]==

Revision as of 07:21, 1 June 2020


Pulseless ventricular tachycardia
Pulseless ventricular tachycardia


Pulseless ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulseless ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography

Cardiac MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulseless ventricular tachycardia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulseless ventricular tachycardia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulseless ventricular tachycardia

CDC on Pulseless ventricular tachycardia

Pulseless ventricular tachycardia in the news

Blogs on Pulseless ventricular tachycardia

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pulseless ventricular tachycardia

File:Pulseless ventriculat tachycardia.jpg For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Synonyms and keywords:

Overview

Pulseless ventricular tachycardia is an often fatal cardiac dysrhythmia where the regular rhythmic contraction of the heart is replaced by non-rhythmic, faster, yet inadequate contractions. These ineffective contractions do not appropriately perfuse the organ, leading to ischemia as well as heart failure. This condition requires immediate medical attention as it is an emergency and can lead to ventricular fibrillation and sudden death.[1]

Historical Perspective

Classification

Pulseless ventricular tachycardia as a ventricular tachycardia, may be classified based on the morphology of the QRS complexes into two subtypes/groups: monomorphic ventricular tachycardia, and polymorphic ventricular tachycardia.

Pathophysiology

Rapid abnormal automaticity and triggered activity are thought to be the main electrophysiological mechanisms of pulseless ventricular tachycardia.

Causes

Structural heart disease is the most common cause of pulseless ventricular tachycardia. Other causes include but are not limited to, drugs/medications, congenital heart diseases, not to mention congenital and inherited channelopathies. It is important to note that QT interval lengthening medications, as well as electrolyte disturbances, can also result in pulseless ventricular tachycardia.[2]

Differentiating Pulseless ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


Template:WH Template:WS

  1. Foglesong A, Mathew D. PMID 32119354 Check |pmid= value (help). Missing or empty |title= (help)
  2. Baldzizhar A, Manuylova E, Marchenko R, Kryvalap Y, Carey MG (September 2016). "Ventricular Tachycardias: Characteristics and Management". Crit Care Nurs Clin North Am. 28 (3): 317–29. doi:10.1016/j.cnc.2016.04.004. PMID 27484660.